Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

uniQure (QURE) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for uniQure (QURE) over the last 10 years, with Q3 2025 value amounting to $5.7 million.

  • uniQure's Gains from Investment Securities rose 3764.79% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year increase of 41376.54%. This contributed to the annual value of $5.6 million for FY2024, which is 3777.78% down from last year.
  • As of Q3 2025, uniQure's Gains from Investment Securities stood at $5.7 million, which was up 3764.79% from -$320000.0 recorded in Q2 2025.
  • In the past 5 years, uniQure's Gains from Investment Securities ranged from a high of $14.2 million in Q3 2023 and a low of -$6.4 million during Q4 2023
  • In the last 5 years, uniQure's Gains from Investment Securities had a median value of $975000.0 in 2023 and averaged $2.1 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 429166.67% in 2023, then crashed by 38492.31% in 2024.
  • uniQure's Gains from Investment Securities (Quarter) stood at $3.8 million in 2021, then surged by 106.33% to $7.9 million in 2022, then plummeted by 181.34% to -$6.4 million in 2023, then surged by 148.75% to $3.1 million in 2024, then soared by 81.53% to $5.7 million in 2025.
  • Its Gains from Investment Securities was $5.7 million in Q3 2025, compared to -$320000.0 in Q2 2025 and $4.0 million in Q1 2025.